RareLens: Towards End-to-End Rare Disease Care via Aligning Divergent Large Language Model Reasoning

• URL: http://arxiv.org/abs/2607.23290v1
• Date: Sat, 25 Jul 2026 16:58:10 GMT
• Title: RareLens: Towards End-to-End Rare Disease Care via Aligning Divergent Large Language Model Reasoning
• Abstract summary: RareLens is a system that supports clinical decision-making across the entire rare disease trajectory.<n>Developed and evaluated on RareBench, a real-world dataset of 157,525 cases spanning all 33 Orphanet categories and more than 7,000 conditions.<n>It achieved an area under the curve of 0.917 for screening and top-1 accuracies of 65.5% and 89.8% for diagnosis and treatment.
• Score: 42.80742579670377
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Rare diseases collectively affect an estimated 3.5% to 5.9% of the population, yet more than 70% of patients are misdiagnosed and many endure years of evaluation before a diagnosis is reached, because early presentations are nonspecific and relevant expertise is scarce and unevenly distributed. Artificial intelligence could provide support, but existing systems address isolated stages of care, overwhelmingly diagnosis. They typically depend on the results of downstream investigations, and they treat the variability between models as noise to be eliminated. Here we present RareLens, a system that supports clinical decision-making across the entire rare disease trajectory by exploiting this variability. When heterogeneous large language models evaluate the same case, they generate divergent but complementary reasoning, which RareLens aligns and calibrates into a single convergent, actionable decision at each stage. Four coordinated modules perform primary-visit risk screening, diagnosis, treatment planning and prognosis. Developed and evaluated on RareBench, a real-world dataset of 157,525 cases spanning all 33 Orphanet categories and more than 7,000 conditions, RareLens outperformed every frontier model tested, including GPT-5, DeepSeek-R1, Claude-3.7-Sonnet and Gemini-2.5-Pro, at each stage. It achieved an area under the curve of 0.917 for screening and top-1 accuracies of 65.5% and 89.8% for diagnosis and treatment. In an external study spanning 1,287 cases and 23 physicians, autonomous RareLens and physicians assisted by RareLens both substantially outperformed unaided physicians. These findings indicate that aligning divergent model reasoning, rather than scaling a single model, offers a generalizable strategy for high-uncertainty clinical decision-making.

Related papers

• TEDDY: A Pediatric Foundation Model for Risk Forewarning from ICD-Coded Diagnostic Histories [4.659237660627583]
  TEDDY (Temporal Event Decoder for Disease in Youth) trained on 73 million ICD-10 diagnoses from 1.6 million children.<n>Across 797 disease-onset prediction tasks spanning 16 ICD-10 chapters, TEDDY achieved a median AUC of 72.0%.<n> Predictive signal remained detectable more than two years before first recorded diagnosis.
  arXiv  Detail & Related papers  (2026-07-15T16:17:28Z)
• A specialized reasoning large language model for accelerating rare disease diagnosis: a randomized AI physician assistance trial [24.92158750857024]
  Large language models (LLMs) show promise to support rare disease diagnosis.<n>RaDaR is an open-source, compact reasoning LLM (32B parameters) for rare disease diagnosis.<n>RaDaR showed the strongest performance among evaluated open-source models.
  arXiv  Detail & Related papers  (2026-06-23T12:42:23Z)
• LiteOdyssey: A Lightweight Reasoning AI Agent for Interpretable Rare-Disease Diagnosis [5.485944483858884]
  LiteOdyssey is a lightweight rare-disease diagnostic framework that guides reasoning language model through a clinical genetics workflow.<n> LiteOdyssey achieved state-of-the-art performance, with an overall disease Recall@1 of 59.3% over the combined 1,243 cases of LIRICAL and the PhenoPacket Store.<n> LiteOdyssey suggests a path toward rare-disease AI systems that are accurate, easier to deploy, and more transparent for physician review.
  arXiv  Detail & Related papers  (2026-06-15T03:10:17Z)
• A Breast Vision Pathology Foundation Model for Real-world Clinical Utility [65.57568187389113]
  We present bfBRAVE, a breast-adaptive pathology foundation model developed and evaluated using a total resource of 101,638 breast wholeslide images.<n>BRAVE supported practical roles in the clinical workflow, including safe exclusion of low-risk cases from routine AI-assisted second-review rescue of initially missed positives and prioritization of cases for further assessment.
  arXiv  Detail & Related papers  (2026-05-06T07:44:39Z)
• Benchmarking Multi-turn Medical Diagnosis: Hold, Lure, and Self-Correction [72.89352076103889]
  Large language models (LLMs) achieve high accuracy in medical diagnosis when all clinical information is provided in a single turn.<n>We introduce MINT, a high-fidelity, multi-turn medical diagnosis benchmark comprising 1,035 cases.<n>We uncover three persistent behavioral patterns that significantly impact diagnostic decisions.
  arXiv  Detail & Related papers  (2026-04-06T00:23:10Z)
• Cerebra: A Multidisciplinary AI Board for Multimodal Dementia Characterization and Risk Assessment [56.62016795093786]
  Cerebra is an interactive multi-agent AI team that coordinates specialized agents for EHR, clinical notes, and medical imaging analysis.<n>It supports privacy-preserving deployment by operating on structured representations and remains robust when modalities are incomplete.<n>Cerebra significantly improved expert performance, increasing accuracy by 17.5 percentage points in prospective dementia risk estimation.
  arXiv  Detail & Related papers  (2026-03-23T05:46:45Z)
• RareAlert: Aligning heterogeneous large language model reasoning for early rare disease risk screening [19.93227904357489]
  We present RareAlert, an early screening system which predict patient-level rare disease risk from routinely available primary-visit information.<n>RareAlert integrates reasoning generated by ten LLMs, calibrates and weights these signals using machine learning, and distils the aligned reasoning into a single locally deployable model.
  arXiv  Detail & Related papers  (2026-01-26T04:27:16Z)
• An Explainable Hybrid AI Framework for Enhanced Tuberculosis and Symptom Detection [55.35661671061754]
  Tuberculosis remains a critical global health issue, particularly in resource-limited and remote areas.<n>We propose a framework which enhances disease and symptom detection on chest X-rays by integrating two supervised heads and a self-supervised head.<n>Our model achieves an accuracy of 98.85% for distinguishing between COVID-19, tuberculosis, and normal cases, and a macro-F1 score of 90.09% for multilabel symptom detection.
  arXiv  Detail & Related papers  (2025-10-21T17:18:55Z)
• An Agentic System for Rare Disease Diagnosis with Traceable Reasoning [69.46279475491164]
  We introduce DeepRare, the first rare disease diagnosis agentic system powered by a large language model (LLM)<n>DeepRare generates ranked diagnostic hypotheses for rare diseases, each accompanied by a transparent chain of reasoning.<n>The system demonstrates exceptional diagnostic performance among 2,919 diseases, achieving 100% accuracy for 1013 diseases.
  arXiv  Detail & Related papers  (2025-06-25T13:42:26Z)
• Deep Learning-based Computational Pathology Predicts Origins for Cancers of Unknown Primary [2.645435564532842]
  Cancer of unknown primary (CUP) is an enigmatic group of diagnoses where the primary anatomical site of tumor origin cannot be determined. Recent work has focused on using genomics and transcriptomics for identification of tumor origins. We present a deep learning-based computational pathology algorithm that can provide a differential diagnosis for CUP.
  arXiv  Detail & Related papers  (2020-06-24T17:59:36Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.